About
Dr. David A. Goldman
Prior to founding his own private practice, David A. Goldman, M.D. served as Assistant Professor of Clinical Ophthalmology at the Bascom Palmer Eye Institute in Palm Beach Gardens. Within the first of his five years of employment there, Dr. Goldman quickly became the highest volume surgeon. He has been recognized as one of the top 250 US surgeons by Premier Surgeon, top 40 under 40 Ophthalmologists in the world by British journal The Ophthalmologist, as well as being awarded a Best Doctor and Top Ophthalmologist. In 2022, Dr. Goldman was ranked the #26 best ophthalmologist out of nearly 25,000 in the United States by Newsweek magazine, followed by #24 ranking in 2023.
Bascom Palmer Eye Institute, fellowship, cornea and external disease Miami, FL
Bascom Palmer Eye Institute, residency, ophthalmology Miami, FL
Cabrini Medical Center, internship, internal medicine New York, NY
Tufts School of Medicine, MD, with honors in research Boston, MA
Cornell University, BA, cum laude in Psychology and with distinction in all subjects Ithaca, NY
2017-2018 Medical Director, New York Eye and Ear/Mount Sinai West Palm Beach
2015 Top 40 under 40 ophthalmologists in the world, The Ophthalmologist
2012-Present Best Doctors
2012-Present Top Ophthalmologist
2010 Premier Surgeon Top 250 Ophthalmic Surgeons in the US
2012-Present Anterior Segment Team Lead, Modernizing Medicine
2012 Florida Society of Ophthalmology Michael R. Redmond, MD Young Outstanding Ophthalmologist Award
2009 Crystalens Center of Excellence Award
2009 Inaugural member, Vanguard Ophthalmology Society
ASCRS 2008 Foundation Research Grant Recipient
ASCRS 2007 Excellence in Research Fellow Scholarship Award
ASCRS Young Physicians and Residents committee member 2007-2010
ASCRS 2006 Excellence in Research Resident Scholarship Award
ASCRS 2005 Excellence in Research Resident Scholarship Award
Nominee, Ophthalmology Times Resident Writer’s Award Program
Founding member and representative, Bascom Palmer Ophthalmology Mission to Haiti
2006 Pan American Association in Ophthalmology Paul Kayser International Scholar
2005 2nd place, ACES Bloomberg Memorial Videotape Competition for cataract surgery
2002 Alpha Omega Alpha Honor Society
2001 AMA Foundation Seed Grant
2001 Alpha Omega Alpha Research Fellowship
2001 and 1999 New England Medical Center General Clinical Research Center grants
1998 Psi Chi Honor Society
American Academy of Ophthalmology
2012-2014 AAO POC Committee Member
American Board of Ophthalmology
2014-2016 Exam writer, American Board of Ophthalmology
2011-2017 Oral board examiner, American Board of Ophthalmology
Alpha Omega Alpha Medical Honor Society
American Society of Cataract and Refractive Surgery
2012-2015 ASCRS Councilor to AAO
2007-2010 ASCRS Young Physicians and Residents committee member
CEDARS/ASPENS Society
Palm Beach Ophthalmology Society
2015,2016 Vice President
2011, 2012 President
Vanguard Ophthalmology Society
Editorial Board, Refractive Eye Care
Editorial Board, Advanced Ocular Care
Editorial Board, Cataract and Refractive Surgery Today
Editorial Board, Millenial Eye
Editorial Board, Ocular Surgery News
MilnerMS, Beckman KA, Luchs JI, Allen QB, Awdeh RM, Berdahl J, Boland TS, Buznego C, Gira JP, Goldberg DF, Goldman D, Goyal RK, Jackson MA, Katz J, Kim T, Majmudar PA, Malhotra RP, McDonald MB, Rajpal RK, Raviv T, Rowen S, Shamie N, Solomon JD, Stonecipher K, Tauber S, Trattler W, Walter KA, Waring GO 4th, Weinstock RJ, Wiley WF, Yeu E. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders – new strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017 Jan;27 Suppl 1:3-47
Goldman DA “February Consultation #8” Journal of Cataract & Refractive Surgery, Vol. 42, Issue 2, p344 2016
Keynote Speaker, 99th Annual Clinical Assembly of the AOCOO-HNS Foundation. “Anterior Segment Effects of Glaucoma Treatments”, “Amniotic Membrane, Surface Disease Treatment”. May 7, 2015 Orlando
Panelist, Surgical Techniques and Ectasia. ASCRS April 18, 2015 San Diego
Film: “Microincisional transcleral fixation of a single-piece intraocular lens” ASCRS San Diego
Keynote Speaker, Washington Academy of Eye Physicians and Surgeons Annual Meeting. “New Diagnostics and Therapeutics for Ocular Surface Disease”, “Corneal Effects of Glaucoma Treatments”, “Complications of Femtosecond Laser Cataract Surgery”, “Pearls for IOL Exchange”. March 20, 2015 Seattle
Goldman DA, Ayres BD, Yoo SH, Devgan U. “Pearls for IOL exchange” ASCRS April 21, 2013 San Francisco
The Conundrum of Glaucoma and the Cornea. Lee; D. Tan; D. A. Goldman; H. F. Edelhauser; R. J. Epstein; F. W. Price; K. Colby; T. W. Samuelson; E. J. Holland. ASCRS April 24, 2012 Chicago
Interactive Video Dialogue on the Complicated Cataract. H. Yoo; I. K. Ahmed; C. E. Starr; U. Devgan; D. A. Goldman; J. Randleman; B. D. Ayres ASCRS April 21, 2012 Chicago
Goldman, DA. “Ultrasound Biomicroscopy” Corneal Imaging Technologies: How to interpret and When to use? April 20, 2012 ASCRS Cornea Day Chicago
Goldman, DA. “Troubleshooting the Unhappy Presbyopic IOL Patient”. Kiawah Eye Meeting. June 4, 2011, Kiawah, SC.
A. Goldman; R. J. Cionni; E. A. Davis; E. D. Donnenfeld; B. Henderson; W. B. Trattler ASCRS Course 27-103: Clinical Pearls for Premium IOLs: 2011 Update. ASCRS 2011, San Diego.
Goldman, DA Prospective Longitudinal Investigation of Peripapillary Retinal Nerve Fiber Layer Thickness Following DSEK. ASCRS Paper Session 2-M. March 27, 2011 San Diego.
Goldman, DA. “Half in half out” (Film Presentation. ASCRS San Diego 2011)
Goldman, DA. “Accomodating IOL Technology” Bascom Palmer Cataract & Refractive Congress 2011, Miami FL.
Goldman DA “Cataract Surgery in Pseudoexfoliation Patients” XXXII Inter-American Course in Clinical Ophthalmology, Miami FL 2010
Etter J, Goldman DA. Association between H1N1 vaccine and Corneal Transplant Rejection, poster.World Cornea Congress Boston 2010.
DA. Goldman; R. J. Cionni; E. A. Davis; U. Devgan; E. D. Donnenfeld; B. Henderson; W. B. Trattler ASCRS Course 13-306: Clinical Pearls for Premium IOLs: 2010 Update. ASCRS 2010, Boston.
Goldman DA. Safety of Cartridge for Implantation of Single-Piece Acrylic IOLs. ASCRS Paper Session 4-E: Intraocular Surgery Phaco Techniques. ASCRS 2010 Boston.
Vedula; R. M. Awdeh; D. A. Goldman Permanent Tattoo of a Descemet–Stripping Endothelial Keratoplasty Button. ASCRS Posters P1: Intraocular Surgery (Cataract and Refractive) ASCRS 2010, Boston.
Randleman; D. M. Blackmon; D. A. Goldman; P. C. Kang; T. M. Harvey; S. W. Reeves; D. L. Seldomridge; L. H. Suh; E. Yeu; I. K. Ahmed; A. J. Aldave; U. Devgan; B. Henderson; D. T. Vroman ASCRS Symposium S-7: Challenging Video Cases for the Young Surgeon ASCRS 2010 Boston.
Randleman; D. M. Blackmon; D. A. Goldman; T. M. Harvey; S. W. Reeves; D. L. Seldomridge ASCRS Skills Transfer Session STS1: OR Time ASCRS 2010, Boston.
Goldman DA. Treatment of Ametropia after Premium IOL Surgery. Bascom Palmer Eye Institute Cataract and Refractive Congress, Miami, FL, February 27, 2010.
Goldman DA. Crystalens Pearls. Bascom Palmer Eye Institute Cataract and Refractive Congress, Miami, FL, February 26, 2010.
Live Cataract Surgeon, 5th International Conference on Ocular Infections, Palm Beach Gardens, FL, February 19, 2010.
Goldman DA. Blepharitis. Royal Hawaiian Eye 2010. Kauai, HI January 21, 2010.
Exam writer, AAO COA Self-Assessment Program 2010
Goldman DA, Intracameral Adjuvants in Cataract Surgery. XXXI Inter-American Course in Clinical Ophthalmology. Bascom Palmer Eye Institute, Miami FL, Nov 1, 2009.
Ehrenhaus M, Tseng S, Trattler W, Yoo S, Majmudar P, Goldman DA, Yeu E. Cornea and Anterior Segment Disasters: Bringing Them Back From the Precipice. American Academy of Ophthalmology Annual Meeting, San Francisco, Oct 25, 2009.
Goldman DA. Treating Blepharitis to Maximize Surgical Success. Cataract and Refractive Surgery Today. May 2009.
Goldman DA, Trattler WB. Cataract Surgery and Diabetic Retinopathy. Ophthalmology (in press)
Galor A, Gonzalez M, Goldman D, O’Brien TP. Intraocular lens exchange surgery in dissatisfied patients with refractive intraocular lenses. J Cataract Refract Surg. 2009 Oct;35(10): 1706-10.
Committee member “Symposium: Challenging Video Cases for the Young Surgeon” ASCRS 2009 San Francisco April 5, 2009.
Panelist, “Intraocular Surgery Cataract Complications” ASCRS 2009 San Francisco April 6, 2009
Faculty, Cornea and Anterior Segment Disasters: Bringing Them Back From the Precipice” ASCRS 2009 San Francisco April 6, 2009.
Faculty, “Clinical Pearls for Premium IOLs” ASCRS 2009 San Francisco April 5, 2009
Faculty, Challenging Premium IOL Cataract Cases” ASCRS 2009 San Francisco April 4, 2009
“Microincisional Phaco” Aspen Cornea Society Aspen, CO 2009
“Transitioning to Microincisional Phacoemulsification” XXX Inter-American Course in Clinical Ophthalmology, Miami FL Nov 16, 2008
Haft P, Kymionis G, Goldman D. Corneal Transplant Rejection. Expert Review of Ophthalmology June 2008, 3(3):293-297.
Ide T, Kymionis GD, Goldman DA, Yoo SH, O’Brien TP. Subconjunctival gas bubble Formation during LASIK flap creation using femtosecond laser. J Refract Surg. 2008 Oct;24(8):850-1.
“Crystalens and YAG: Friends or Mortal Enemies” Bascom Palmer Cataract & Refractive Congress, Miami 2008
“Flomax: How to tame the Iris” Bascom Palmer Cataract & Refractive Congress, Miami 2008
Yoo SH, Kymionis GD, Koreishi A, Ide T, Goldman D, Karp CL, O’Brien TP, Culbertson WW, Alfonso EC. Femtosecond Laser-Assisted Sutureless Anterior Lamellar Keratoplasty. Ophthalmology 2008 Aug;115(8):1303-7, 1307.e1. Epub 2008 Jan 2.
Kymionis GD, Goldman D, Ide T, Yoo, SH. Tacrolimus ointment 0.03% in the eye for the treatment of giant papillary conjunctivitis. Cornea 2008 Feb;27(2):228-9.
David A. Goldman, Jennifer I. Hui. Chapter 7. Lens. Ocular Trauma 2007: 89-102.
“In the Clinic with the Experts” panelist, ASCRS 2007.
Goldman DA, Alfonso EC. Alfonso Corneal Transplant Diamond Knife (film presentation, ASCRS San Diego 2007)
Goldman D, O’Brien T. Multifocal intraocular lenses and posterior capsule opacification. Bascom Palmer Eye Institute Cataract and Refractive Congress, Miami Feb 10, 2007.
Goldman D, Dave S, Culbertson W, O’Brien T. Corneal collagen cross linking. Bascom Palmer Eye Institute Cataract and Refractive Congress, Miami Feb 10, 2007.
Goldman D, O’Brien T. DSEK Rejection. Bascom Palmer Eye Institute Cataract and Refractive Congress, Miami Feb 9, 2007.
Goldman D, Koreishi A, Yoo S, Culbertson W, Alfonso E. Sutureless Anterior Lamellar Keratoplasty (SALK) performed with a femtosecond laser. Cornea Society, Las Vegas Nov 10, 2006.
Yoo S, Culbertson W, Alfonso E, Goldman D, Price F, Steinert R. Custom-shaped “Top Hat” penetrating keratoplasty using a femtosecond laser. International Society of Refractive Surgery of the American Academy of Ophthalmology meeting, Istanbul, Turkey May 26-28, 2006.
Goldman DA, Koreishi A, Yoo S, Culbertson W, Alfonso E. Sutureless Anterior Lamellar keratoplasty utilizing the Intralase femtosecond laser. International Society of Refractive Surgery of the American Academy of Ophthalmology meeting, Istanbul, Turkey May 26-28, 2006.
Mason B, Goldman D, Miller D, Lee W. Finding INfectious Growths on the Extremities of Residents (FINGER) study. Association for Research in Vision and Ophthalmology (ARVO). 2006; Program #265, Poster #B254.
Goldman DA, Miller D, Alfonso EC. Voriconazole in the treatment of Aspergillus Glaucus Corneal Ulcer. Association for Research in Vision and Ophthalmology (ARVO). 2006; Program #411, Poster #B34.
Goldman D, Yoo S. Lamellar corneal patch graft construction utilizing Intralase femtosecond laser (film presentation, ASCRS San Francisco 2006)
Goldman D, Moore J, Greuloch K, Flynn HW. Cyclodialysis and hypotony maculopathy. Ophthalmic Surg Lasers Imaging. 2006 Sep-Oct; 37(5):438-9.
Goldman D, Schatz N: Patient has decreased vision, headaches: What is diagnosis? Fundoscopic examination reveals optic disc swelling, visual fields show abnormalities. Ophthalmology Times 30(6): 16-18, March 15, 2005.
DA Goldman, S Yoo “Cataract surgery in the face of retrobulbar hemorrhage” 2nd annual Southeastern conference at MUSC, Charleston, SC, March 5, 2005.
Goldman D, Johnson T, Dubovy S, Lee W, Tse D: Referred patient has decreased vision, orbital mass. Pupils, visual fields show abnormalities, imaging studies demonstrate mass: What is the diagnosis? Ophthalmology Times 29(12): 18-20, June 15, 2004.
DA Goldman, JK Moore, KW Greuloch, CE Callahan, HW Flynn. Hypotony maculopathy following traumatic cyclodialysis: OCT features and clinical outome. International Society for Imaging in the Eye. Ft. Lauderdale, FL. April 23-24, 2005.
DA Goldman, B Yashar, KR Wollenberg, E Filippova, CA Puliafito, A Swaroop, and ME Fini. No Evidence for Association between Specific Transforming Growth Factor-Beta1 (TGF-ß1) Polymorphisms and Age-Related Macular Degeneration (AMD). Ophthalmol. Vis. Sci. 2002 43: E-Abstract 2835.
Kahan D, Gandhi N, Goldman D, Saloman R, Melanson A, Horth B, Dixon M, Chabot D, Perrone R, Salm K, Freeman R. High producing tumor necrosis alpha (TNF-A) gene polymorphism is associated with chronic renal allograft dysfunction (CRAD). American Journal of Transplantation. Vol 1:399, 2001 Suppl. 1.
Kahan D, Mason T, Gandhi N, Goldman D, Melanson A, Horth B, Dixon M, Supran S, Saloman R, Delmonico F, O’Connor K, Rohrer R, Freeman R. Donor cytokine gene polymorphisms are associated with increased graft loss and dysfunction after transplant. American Journal of Transplantation. Vol.1: 361,2001 Suppl. 1.
Gandhi N, Goldman D, Kahan D, Supran, S, Saloman, R, Delmonico F, O’Connor K, Freeman R. Donor cytokine gene polymorphisms are associated with increased graft loss and dysfunction after transplant. Transplantation Proceedings. 33 (1-2): 827-828, 2001.
Goldman D, Gandhi N, Barhyte DY, Barhyte D, Saloman R, Light J, Freeman R. Racial differences in cytokine gene polymorphism frequencies do not explain increased acute renal transplant rejection rates among African Americans. Transplantation. 69(8):S187, 2000.
Phillips JC, Goldman DA, Wiggs JL. Identification and Physical Mapping of the Human NLI gene and its screening as a Candidate Gene for Aphakia. Association for Research in Vision and Ophthalmology (ARVO). 1998; Program #2365, Poster #B222.
Phillips JC, Goldman, DA, DelBono EA, Haines JL, Wiggs JL. Isolation and characterization of candidate genes for Rieger syndrome. American Journal of Human Genetics. 1997; 61:(4) 2010 Suppl. S.
Dr. Mark S. Milner
Mark S. Milner, M.D. is a board-certified ophthalmologist nationally and internationally recognized for his expertise in corneal surgery and dry eye management. Dr. Milner is an Associate Clinical Professor at Yale University Medical School, Department of Ophthalmology. He has been a principal investigator for several studies for FDA approval and has authored various publications, including a 44 page peer reviewed article in Current Opinion in Ophthalmology (January 2017) detailing his innovative algorithm and approach to the diagnosis and treatment of dry eye disease. He has been interviewed by several magazines, newspaper, radio and television shows about his refractive and corneal expertise. He was also the only ophthalmologist between NY and Boston to perform the IMT (Implantable Miniature Telescope) surgery for patients with advanced macular degeneration and blindness. Dr. Milner specializes in cornea, external diseases, refractive surgery and uveitis, with a focused interest in dry eye disease and dysfunctional tear syndrome. He has lectured throughout the world teaching other physicians about dry eye and his innovative approach, algorithm and treatments. He has also been recognized by Ocular Surgery News as one of the top 300 innovative ophthalmologists in the country. In 2022, Dr. Milner was ranked the #144 best ophthalmologist out of nearly 25,000 in the United States by Newsweek magazine, followed by a top 150 ranking in 2023.
Francis I. Proctor Foundation UCSF, fellowship, cornea, external disease, uveitis San Francisco, CA
New York Eye and Ear Infirmary, residency, ophthalmology New York, NY
UMDNJ., Robert Wood Johnson University Hospital, internship New Brunswick, NJ
S.U.N.Y. Health Science Center , MD Syracuse, NY
Union College, BA, magna cum laude Biology-Psychology. Schenectady, NY
2016 Ocular Surgery News (OSN) Premier Surgeon 300 as one of the top 300 premier surgeons and leading innovators in the U.S. in the field of refractive cataract surgery.
2009, 2010, 2011, 2012, 2013, 2014 and 2015 “Top Doctor” in Connecticut Magazine
1998 Yale Department of Ophthalmology Teaching Award for “Excellence in Teaching”
1993 Chief Resident, awarded by residents and attendings at New York Eye and Ear Infirmary
American Academy of Ophthalmology
American Medical Association
American Society for Cataract and Refractive Surgery
International Society for Refractive Surgery
CEDARS/ASPENS Society – Founding Member; Board member (2020)
Ocular Microbiology and Immunology Group
Palm Beach County Ophthalmology Society
The Cornea Society
“The Potential Role of Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren’s Syndrome Diagnosis.” Beckman KA, Luchs J, Milner MS, Adv Ther., 2017 Mar 10
“Dysfunctional Tear Syndrome: dry eye disease and associated tear film disorders – new strategies for diagnosis and treatment.”, Milner, MS, Beckman, KA, and Luchs, J, Curr Opin Ophthalmol., 2017 Jan;27 Suppl 1:3-47.
“A Prospective, Multi-center, Randomized, Double- masked, Positive-controlled Phase 3 Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate Ophthalmic Suspension (1%) in Patients with Non-infectious Anterior Segment Uveitis.” , Principal Investigator, FDA Study, 2016
“Making the diagnosis of Sjögren’s syndrome in patients with dry eye.” Beckman KA, Luchs J, Milner MS,
Clin Ophthalmol. 2015 Dec 24;10:43-53.
“A Multi-Center, Double-Masked, Randomized, One-Year Safety Study of EBI-005 5mg/mL Topical Ophthalmic Solution
versus Vehicle-Control in Subjects with Dry Eye Disease (DED)”, Principal Investigator, FDA Study, 2015.
“ A Phase 2, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared with Vehicle
in Subjects with Dry Eye Disease”, Principal Investigator, FDA Study, 2014
“A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5mg/mL Topical Ophthalmic
Solution versus Vehicle Control in Subjects with Moderate to Severe Dry Eye Disease (DED)”, Principal Investigator, FDA Study,
2014
“A Prospective, Multi-Center, Randomized, Double-Masked, Positive-Controlled Phase 3 Clinical Trial Designed to Evaluate
the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate
Ophthalmic Suspension (1%) in Patients with Non-Infectious Anterior Segment Uveitis”, Principal Investigator, FDA Study, 2012
“PERSIST: Physician’s Evaluation of Restasis Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for
dry eye; a retrospective review”, Mah, Francis, Milner, Mark, Yiu, Samuel, Donnenfeld, Eric, Conway, Taryn, and Hollander,
David A., Clinical Ophthalmology, 2012: 6, 1-6.
“A Multi-Center, Retrospective Study of the Initial Clinical Practice Patterns in Assessment and Treatment of Ocular Surface
Disease Patients.”, Ocular Surface Alliance, Principal Investigator, Poster, ASCRS 2011.
“Dysfunctional tear syndrome: an innovative approach to diagnosis and treatment” – Mark S. Milner, MD
DRY EYE SYMPOSIUM; Audio-Digest Ophthalmology; Volume 48, Issue 18; September 21, 2010
“Retrospective Chart Review of Patients’ Second Trial of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% S Preservative Free”, Principal Investigator, Poster, AAO Meeting, Chicago, IL, October 2010.
“A Multi-Center, Parallel-Group, Double-Masked, Randomized, Placebo-Controlled Study of the Effects of diquafasol
tetrasodium, Ophthalmic Solution, 2% in Subjects with Dry Eye Disease and a Central Corneal Staining Score of 3 (NEI Scale)”,
Principal Investigator, FDA Study, 2009.
“A Randomized, Multi-Center, Double-Masked, Placebo-Controlled, Parallel-Group Safety and Efficacy Study of Azithromycin
Ophthalmic Solution, 1% versus Placebo for Two Weeks in Subjects with Blepharitis”, Principal Investigator, FDA Study,
2009.
Sunrise Laser Thermal Keratoplasty (LTK) for Correction of Hyperopia +1.25 to +5.625 Diopters, 32 spot LTK Treatment
Principal Investigator, FDA Study, Feb. 2000 to 2002
“Herpes Zoster Ophthalmicus in Patients with Human Immunodeficiency Virus Infection”. Margolis, T.P., Milner, M.S.,
Shama, A., et al, American Journal of Ophthalmology, 125(3), 285-91, Mar. 1998.
“High Resolution Ultrasound Biomicroscopy of the Anterior Segment in Patients with Dense Corneal Scars”,
Milner, M., Liebmann, J., Tello, C., et al., Ophthalmic Surgery, 25 (5), 284-7, May 1994.
“Histoplasmosis of the Eyelid in a Patient with AIDS”, Milner, M.S., McCormick, S., Speaker, M.G., Accardi, F.,
Case presentation at the OMIG section of the AAO meeting, Nov., 1993
“Topical Chemotherapy for Conjunctival Melanoma”, Finger, P.T., Milner, M.S., and McCormick, SA
British Journal of Ophthalmology, 77 (11), 751-3, Nov. 1993.
“Pathogens in Corneal Ulceration Associated with Disposable Contact Lenses”, Nissen, M., Speaker, M.G.,
Milner, M., et al. Poster presented at the AAO Meeting, Nov., 1992.
“Halogenated Inhalation Anesthetic Agents Decrease Transepithelial Electrical Measurements Across the Isolated Iris-Ciliary Body”,
Tang, L. ‘ Krupin, T., Milner, M., et al., Investigative Ophthalmology and Visual Science, Vol. 32, No 5, May 1991.
Dr. Yissell Sanchez Acosta
Yissell Sanchez, O.D. is a licensed optometrist and obtained her Doctor of Optometry degree and a Bachelor of Science in the field of Visual Science from Nova Southeastern University College of Optometry. She continued her optometric training by completing an Ocular Disease residency at the Bascom Palmer Eye Institute, graduating one of the top in her class. Dr. Sanchez is highly proficient in the detection and management of ocular disease including diabetes, glaucoma, macular degeneration, dry eyes, and tearing disorders. Dr. Sanchez speaks English and Spanish fluently.
Our technology
OPD-Scan III
The OPD-Scan III is an autorefractor, keratometer, pupillometer (up to 9.5mm), corneal topographer, and integrated wavefront aberrometer. The OPD-Scan III completes 20 diagnostic metrics in less than 10 seconds per eye (including angle kappa, HOAs, average pupil power, RMS value, and point spread function). Easy alignment and automatic capture of wavefront aberrometry data ensures accurate readings. Wavefront aberrometry data is gathered from available zones up to a 9.5mm area, adding the capability to provide for calculation of mesopic refractions. Blue light, 33 ring, placido disc topography is gathered in one second. Mapping methods include OPD, visual acuity corneal topography/topographer, and more.
Zeiss Atlas 9000
The ATLAS 9000 CT System combines sophisticated analysis and advanced imaging into a highly intuitive, user-friendly platform. The ATLAS is ideal for primary care, contact lens fitting, pathology detection and corneal refractive surgery management applications.
Pentacam HR
The Pentacam® HR is a high-resolution rotating Scheimpflug camera system for anterior segment analysis. It provides crisp images of cornea, iris and crystalline lens. It measures the anterior and posterior corneal topography and elevation, total corneal refractive power, corneal power distribution, automatic chamber angle measurement in 360°, chamber depth and volume, HWTW, corneal and crystalline lens optical opacities.
Optos California
Optos introduced ultra-widefield (UWF™) retinal imaging to enable eyecare professionals to discover, diagnose, document and treat ocular pathology that may first present in the periphery – pathology which may go undetected using traditional examination techniques and equipment. Their UWF, high-resolution retinal imaging devices each image more than 80% or 200˚ of the retina in a single capture.
Zeiss OCT
CIRRUS HD-OCT is configured with the highest resolution visualization capabilities and sophisticated clinical applications such as Advanced RPE analysis to track retinal pigment epithelial integrity and Ganglion Cell Analysis to assess glaucomatous loss in the macula that may not be evident in the peripapillary region. The new FastTrac™ retinal tracking reduces eye motion artifacts without sacrificing patient throughput with a proprietary scan acquisition strategy, high speed 20 Hz LSO camera, and single-pass alignment scanning. This feature enables the highest resolution B-Scans to be captured in identical locations from visit to visit providing precise assessment of change in targeted pathologies. Our OCT is equipped with both cornea and anterior chamber modules to allow anterior segment analysis such as non contact goniometry.
Zeiss Humphrey Field Analyzer 3
The Zeiss HFA3 is the latest version of the gold standard automated perimetry. With the latest SITA-faster testing strategy, testing times can be reduced by as much as 50% compared to traditional visual field devices.
IOL Master 700
The IOL Master 700 is the latest swept source OCT biometer that allows measurement of the anterior and posterior curvatures of the cornea. With total cornea measurements and full cornea to retina scans, accuracy for traditional and complex cataract surgeries such as post-lasik patients is greatly increased.
Konan Cellchek XL
The Konan Cellchek XL delivers cellular level imaging of the corneal endothelium with the industry’s most comprehensive tools for cellular morphology and trending analysis. The system is used globally for routine clinical use including many of the leading medical and surgical applications such as: ICLs (FDA labeling requires), cataract surgery and premium IOLs, glaucoma medication assessment, DSEK / DMEK, keratoconus, and corneal cross-linking (CXL). Many clinicians also use specular microscopy for clinical assessment of contact lens related corneal distress.
As a fully automated system, the CellChek XL includes non-contact pachymetry and peripheral analysis features critical for following tissue transplantation procedures. The microscope system includes 19″ touch screen, motorized table, and printer. Konan provides on-site training, advanced topics web-enabled training and the industry’s best clinical support.
Diopsys Nova
Diopsys is the world-leading provider of modern visual electrophysiology solutions and trusted thought leader in the medical eye care community. This technology helps eye care professionals accurately and objectively measure retinal and visual pathway function.
Haag-Streit XOMA lane
The XOMA Exam Room System offers a captivating, contemporary design. But even more important is the solid thinking behind its appearance. The advances—a more convenient patient education system and improved ergonomics—were refined through extensive and in-depth user testing. With integrated IM900 imaging system and state of the art BQ slit lamp system, this package offers the best examination for ophthalmologists to detect ocular pathology.
RxSight Light Delivery Device
The RxSight Light Delivery Device is used in conjunction with the Light Adjustable Lens (LAL) to deliver optimal postop refractive results following cataract surgery. Goldman Eye is the first practice in Palm Beach, Broward, Martin, and Treasure Coast counties to offer this groundbreaking technology.
Patient Reviews
All reviews are from verified patients